LOC286177: A Potential Drug Target and Biomarker (G286177)
LOC286177: A Potential Drug Target and Biomarker
LOC286177 is a gene that has not yet been characterized, but it is known to encode a protein that is expressed in various tissues of the body. The protein produced by LOC286177 has been shown to play a role in several cellular processes, including cell adhesion, migration, and invasion. Based on these findings, it is possible that LOC286177 may be a drug target or biomarker. In this article, we will explore the potential role of LOC286177 as a drug target and biomarker.
The Protein Produced by LOC286177
LOC286177 is a gene that encodes a protein named ZNF214. ZNF214 is a transcription factor that has been shown to play a role in several cellular processes, including cell adhesion, migration, and invasion. ZNF214 is composed of multiple domains, including an N-terminal transmembrane domain, a nuclear localization domain, and a C-terminal TADZ domain. The N-terminal transmembrane domain is responsible for the protein's ability to enter the nucleus and interact with transcription factors, while the C-terminal TADZ domain is involved in the protein's stability and function.
Expression of LOC286177
LOC286177 is expressed in a variety of tissues and cells of the body. For example, it has been shown to be expressed in the brain, heart, liver, and pancreas. Additionally, the protein produced by LOC286177 has been shown to be involved in several cellular processes, including cell adhesion, migration, and invasion. For example, studies have shown that LOC286177 is involved in the migration of cancer cells through the bloodstream.
Potential Role of LOC286177 as a Drug Target
Based on its involvement in cellular processes and its potential functions, LOC286177 may be an attractive drug target. Drugs that target specific proteins, such as LOC286177, have been shown to be effective in treating a variety of diseases, including cancer. By blocking the function of LOC286177, it is possible to inhibit the growth and spread of cancer cells.
LOC286177 may also be a useful biomarker for certain types of cancer. For example, LOC286177 has been shown to be overexpressed in several types of cancer, including lung cancer and colorectal cancer. This suggests that LOC286177 may be a useful biomarker for these types of cancer.
Conclusion
LOC286177 is a gene that has not yet been fully characterized, but it is known to encode a protein that is involved in several cellular processes. The protein produced by LOC286177 has been shown to play a role in cell adhesion, migration, and invasion, and it may be an attractive drug target or biomarker. Further research is needed to fully understand the role of LOC286177 in cellular processes and its potential as a drug target or biomarker.
Protein Name: Uncharacterized LOC286177
More Common Targets
LOC286297 | LOC286359 | LOC286437 | LOC338694 | LOC339059 | LOC339166 | LOC339260 | LOC339352 | LOC339593 | LOC339666 | LOC339685 | LOC339760 | LOC339975 | LOC340090 | LOC340184 | LOC340512 | LOC343052 | LOC344967 | LOC349160 | LOC374443 | LOC375196 | LOC387720 | LOC388242 | LOC388780 | LOC389199 | LOC389473 | LOC389765 | LOC389831 | LOC389834 | LOC389895 | LOC389906 | LOC390282 | LOC390705 | LOC391092 | LOC391343 | LOC391813 | LOC392180 | LOC392196 | LOC392232 | LOC399783 | LOC399900 | LOC400347 | LOC400464 | LOC400499 | LOC400541 | LOC400576 | LOC400622 | LOC400627 | LOC400682 | LOC400692 | LOC400706 | LOC400707 | LOC400768 | LOC400940 | LOC401021 | LOC401052 | LOC401127 | LOC401261 | LOC401312 | LOC401324 | LOC401357 | LOC401410 | LOC401478 | LOC401480 | LOC401557 | LOC401589 | LOC401703 | LOC401913 | LOC402221 | LOC403312 | LOC407835 | LOC414300 | LOC439933 | LOC440157 | LOC440300 | LOC440311 | LOC440313 | LOC440700 | LOC440864 | LOC440895 | LOC440910 | LOC440982 | LOC441052 | LOC441081 | LOC441087 | LOC441179 | LOC441228 | LOC441239 | LOC441455 | LOC441666 | LOC441722 | LOC441956 | LOC442028 | LOC442497 | LOC497256 | LOC541473 | LOC550113 | LOC553139 | LOC554206 | LOC574080
